Impact of clinical pharmacist interventions in use of oral anti-clotting agents

Author: 
Priyanka.CH., A.Mounikakumari., R.Priyanka and P.Sharmilanirojini

Anticoagulants and antiplatelet agents are medicines that reduce blood clotting in an artery, a vein or the heart. Blood clots can block the blood flow to your heart muscle and cause a heart attack. They can also block blood flow to your brain, causing a stroke. Pharmacist’s unique knowledge of pharmacology, pharmacokinetics and interactions makes them well-suited to assist patients in maintaining safe and effective therapy. Successful therapy improves patient adherence, implies fewer incidences of therapeutic failures and bleeding complications. A total of 187 patients with anti-clotting therapy was randomised and analysed, Knowledge was assessed to both groups before and after education, in control group has no significant difference in score from 2.39±2.18 to 2.50±2.30 (P=0.078), in intervention group score was improved from 2.15±1.67 to 3.98±2.05 (p=0.001)and adherence score by Mo risky scale in intervention group improved from 4.01±1.84 to 2.07±1.32 (p=0.001) and in control group no difference 3.80±1.84 to 3.72±1.81 (p=0.2387) and 24 interactions and 16adverse effectsreported in control group due to lack of knowledge and in intervention group8 interactions and 8adverse effects were reported.This concludes that pharmacist intervention play anrole in improving adherence, and quality of life.

Download PDF: 
DOI: 
http://dx.doi.org/10.24327/ijcar.2018.14515.2632
Select Volume: 
Volume7